Privia Health Group, Inc. (PRVA)

Market Cap	2.71B -8.5%
Revenue (ttm)	2.25B +24.7%
Net Income	21.76M +39.3%
EPS	0.17 +41.3%
Shares Out	126.01M
PE Ratio	126.87
Forward PE	69.75
Dividend	n/a
Ex-Dividend Date	n/a

Volume	952,626
Open	21.52
Previous Close	21.59
Day's Range	21.35 - 21.79
52-Week Range	18.77 - 26.51
Beta	0.97
Analysts	Strong Buy
Price Target	31.53 (+46.58%)
Earnings Date	May 7, 2026

About PRVA

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers’ workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates acc...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Apr 29, 2021
• Employees: 1,226
• Stock Exchange: NASDAQ
• Ticker Symbol: PRVA
• Website: https://www.priviahealth.com

Financial Performance

In 2025, Privia Health Group's revenue was $2.12 billion, an increase of 22.26% compared to the previous year's $1.74 billion. Earnings were $22.92 million, an increase of 59.33%.

Analyst Summary

According to 20 analysts, the average rating for PRVA stock is "Strong Buy." The 12-month stock price target is $31.53, which is an increase of 46.58% from the latest price.

Price Target

$31.53

(46.58% upside)

Analyst Consensus: Strong Buy